FMFang Mei

Fang Mei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fang Mei has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaodong Cheng

    Department of Integrative Biology & Pharmacology, Texas Therapeutics Institute, University of Texas Health Science Center at Houston, Houston, TX 7000, USA

    5 shared publications
  • Hua Liu

    Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, United States

    3 shared publications
  • Wenbo Zhang

    Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, United States

    3 shared publications
  • Wenli Yang

    Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, Texas, USA; The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center, Houston, Texas, USA

    3 shared publications
  • Wei Lin

    The University of Texas Health Science Center, United States

    2 shared publications
  • Dan Li

    Department of Chemical Engineering The University of Melbourne Parkville VIC 3082 Australia

    1 shared publication

Latest Publications

  • Role of exchange proteins directly activated by cAMP signaling in vascular remodeling

    by Xiaodong Cheng, Hua Liu, Wenbo Zhang, Wenli Yang, Fang Mei


  • Role of Ultrasound and Ultrasound‐Based Prediction Model in Differentiating Follicular Thyroid Carcinoma From Follicular Thyroid Adenoma

    by Fan Zhang, Fang Mei, Wen Chen, Yongyue Zhang

    Objectives: This study aims to identify distinct ultrasound (US) characteristics for distinguishing follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA), and construct a user‐friendly preoperative risk stratification model for thyroid follicular neoplasms.Methods: In this retrospective study, patients diagnosed with pathologically confirmed FTA or FTC and undergoing US examinations between July 2017 and June 2021 were designated as the training cohort, and those from July 2021 to June 2023 were enrolled as the external validation set. We systematically assessed and compared the sonographic and clinical characteristics of FTC and FTA. Univariable and multivariable logistic regression analyses were used to assess the association of US features with FTC in the training set. A prediction nomogram model, incorporating US features independently associated with FTC, was developed and validated externally to assess its performance.Results: A total of 645 patients (FTA/FTC = 530/115) were included in the training set, while 197 patients (FTA/FTC = 165/32) constituted the validation set. In the training set, solid composition, hypo‐echogenicity, irregular margin, calcification, protrusion sign, trabecular formation, absent or thick halo, and mainly central hypervascularity were identified as independent factors associated with FTC. The prediction nomogram model constructed using these variables showed good performance in differentiating FTC from FTA with an area under the curve of 0.948 in the training set and 0.915 in the validation set.Conclusions: The preoperative nomogram model constructed based on US features serves as an effective tool for the risk stratification of thyroid follicular neoplasms.


  • Open Access

    Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?

    by Xiaodong Cheng, Wenli Yang, Wei Lin, Fang Mei

    Protein SUMOylation is a major post-translational modification important for maintaining cellular homeostasis. SUMOylation has long been associated with stress responses as a diverse array of cellular stress signals are known to trigger rapid alternations in global protein SUMOylation. In addition, while there are large families of ubiquitination enzymes, all SUMOs are conjugated by a set of enzymatic machinery comprising one heterodimeric SUMO-activating enzyme, a single SUMO-conjugating enzyme, and a small number of SUMO protein ligases and SUMO-specific proteases. How a few SUMOylation enzymes specifically modify thousands of functional targets in response to diverse cellular stresses remains an enigma. Here, we review recent progress toward understanding the mechanisms of SUMO regulation, particularly, the potential roles of liquid-liquid phase separation/biomolecular condensates in the regulation of cellular SUMOylation during cellular stresses. In addition, we discuss the role of protein SUMOylation in pathogenesis and the development of novel therapeutics targeting SUMOylation. Significance Statement Protein SUMOylation is one of the most prevalent post-translational modifications and plays an important role in maintaining cellular homeostasis in response to stresses. Protein SUMOylation has been implicated in human pathogenesis such as cancer, cardiovascular diseases, neurodegeneration, and infection. After more than a quarter century of extensive research, intriguing enigmas remain regarding the mechanism of cellular SUMOylation regulation and the therapeutic potential of targeting SUMOylation.


  • Open Access

    Epac1 activation by cAMP regulates cellular SUMOylation and promotes the formation of biomolecular condensates

    by Wenli Yang, William G. Robichaux, Fang C. Mei, Wei Lin, Li Li, Sheng Pan, Mark A. White, Yuan Chen, Xiaodong Cheng

    Protein SUMOylation plays an essential role in maintaining cellular homeostasis when cells are under stress. However, precisely how SUMOylation is regulated, and a molecular mechanism linking cellular stress to SUMOylation, remains elusive. Here, we report that cAMP, a major stress-response second messenger, acts through Epac1 as a regulator of cellular SUMOylation. The Epac1-associated proteome is highly enriched with components of the SUMOylation pathway. Activation of Epac1 by intracellular cAMP triggers phase separation and the formation of nuclear condensates containing Epac1 and general components of the SUMOylation machinery to promote cellular SUMOylation. Furthermore, genetic knockout of Epac1 obliterates oxidized low-density lipoprotein–induced cellular SUMOylation in macrophages, leading to suppression of foam cell formation. These results provide a direct nexus connecting two major cellular stress responses to define a molecular mechanism in which cAMP regulates the dynamics of cellular condensates to modulate protein SUMOylation.


  • Open Access

    Neuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension

    by Wei Liu, Yonju Ha, Fan Xia, Shuang Zhu, Yi Li, Shuizhen Shi, Fang C. Mei, Kevin Merkley, Gianmarco Vizzeri, Massoud Motamedi, et al.

    Progressive loss of retinal ganglion cells (RGCs) leads to irreversible visual deficits in glaucoma. Here, we found that the level of cyclic AMP and the activity and expression of its mediator Epac1 were increased in retinas of two mouse models of ocular hypertension. Genetic depletion of Epac1 significantly attenuated ocular hypertension–induced detrimental effects in the retina, including vascular inflammation, neuronal apoptosis and necroptosis, thinning of ganglion cell complex layer, RGC loss, and retinal neuronal dysfunction. With bone marrow transplantation and various Epac1 conditional knockout mice, we further demonstrated that Epac1 in retinal neuronal cells (especially RGCs) was responsible for their death. Consistently, pharmacologic inhibition of Epac activity prevented RGC loss. Moreover, in vitro study on primary RGCs showed that Epac1 activation was sufficient to induce RGC death, which was mechanistically mediated by CaMKII activation. Taken together, these findings indicate that neuronal Epac1 plays a critical role in retinal neurodegeneration and suggest that Epac1 could be considered a target for neuroprotection in glaucoma.


  • Open Access

    Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling

    by Hua Liu, Fang C. Mei, Wenli Yang, Hui Wang, Eitan Wong, Jingjing Cai, Emma Toth, Pei Luo, Yue-Ming Li, Wenbo Zhang, et al.

    Epac1 promotes pathological blood vessel formation and is a therapeutic target for vasoproliferative diseases.


  • Electrospun Poly(L-lacticacid)/Nano-Hydroxyapatite Hybrid Nanofibers and Their Potential in Dental Tissue Engineering

    by M. M. Xu, Fang Mei, Dan Li, Xiao Ping Yang, Gang Sui, Xu Liang Deng, X. Y. Hu

    Efficacy of poly(L-lactic acid) (PLLA)/nano-hydroxyapatite(HA) hybrid nanofibrous scaffolds for dental tissue engineering is described and their performance on normal cells with MG-63 is compared as well in this study. Perfectly PLLA/HA fibrous scaffolds were fabricated by an electrospinning process under optimal condition. Cell culcure and adenovirus encoding green fluorenscent protein technique were used to study the morphology of cells grown on the scaffolds. The results show that the growth of DPSCs and PCs is well observed attached to the PLLA/HA fibers, as well as MG-63, which indicate that the nanofibrous PLLA/HA scaffold could be used as a potential cell carrier in dental tissue engineering.